ArticleFrontiers in immunology2023

Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines.

Katarzyna Węgierek-Ciura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.